American Portfolios Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $12.1K | Sell |
1,500
-481
| -24% | -$3.88K | ﹤0.01% | 2443 |
|
|
2022
Q2 | $14.9K | Buy |
1,981
+127
| +7% | +$955 | ﹤0.01% | 2375 |
|
|
2022
Q1 | $17.4K | Hold |
1,854
| – | – | ﹤0.01% | 2446 |
|
|
2021
Q4 | $14.9K | Hold |
1,854
| – | – | ﹤0.01% | 2451 |
|
|
2021
Q3 | $18.1K | Buy |
1,854
+597
| +47% | +$5.82K | ﹤0.01% | 2327 |
|
|
2021
Q2 | $12.4K | Sell |
1,257
-492
| -28% | -$4.87K | ﹤0.01% | 2407 |
|
|
2021
Q1 | $20.2K | Buy |
1,749
+473
| +37% | +$5.46K | ﹤0.01% | 2066 |
|
|
2020
Q4 | $12.3K | Sell |
1,276
-926
| -42% | -$8.94K | ﹤0.01% | 2014 |
|
|
2020
Q3 | $19.8K | Sell |
2,202
-442
| -17% | -$3.98K | ﹤0.01% | 1703 |
|
|
2020
Q2 | $32.6K | Buy |
2,644
+169
| +7% | +$2.08K | ﹤0.01% | 1448 |
|
|
2020
Q1 | $22.2K | Sell |
2,475
-108
| -4% | -$970 | ﹤0.01% | 1495 |
|
|
2019
Q4 | $25.3K | Sell |
2,583
-333
| -11% | -$3.26K | ﹤0.01% | 1631 |
|
|
2019
Q3 | $20.1K | Sell |
2,916
-626
| -18% | -$4.31K | ﹤0.01% | 1656 |
|
|
2019
Q2 | $32.7K | Sell |
3,542
-1,515
| -30% | -$14K | ﹤0.01% | 1459 |
|
|
2019
Q1 | $79.3K | Buy |
5,057
+341
| +7% | +$5.35K | 0.01% | 982 |
|
|
2018
Q4 | $72.7K | Buy |
4,716
+351
| +8% | +$5.41K | 0.01% | 861 |
|
|
2018
Q3 | $94K | Buy |
4,365
+1,350
| +45% | +$29.1K | 0.01% | 855 |
|
|
2018
Q2 | $73.3K | Buy |
3,015
+1,238
| +70% | +$30.1K | 0.01% | 934 |
|
|
2018
Q1 | $30.4K | Sell |
1,777
-3,385
| -66% | -$57.9K | ﹤0.01% | 1217 |
|
|
2017
Q4 | $97.8K | Buy |
+5,162
| New | +$97.8K | 0.02% | 738 |
|